After being warned by the U.S. Food & Drug Administration (FDA) in 2013 to “immediately discontinue” their services, 23andMe is…
Read More
Aerie Pharmaceuticals’ eye drop succeeds in late-stage study
Drugmaker Aerie Pharmaceuticals Inc said on Wednesday its experimental eye drop met the main goal of a late-stage study, sending…
Read MoreMedical data, cybercriminals’ holy grail, now espionage target
SINGAPORE – Whoever was behind the latest theft of personal data from U.S. government computers, they appear to be following…
Read MoreShort people’s genes may confer higher heart risks, study says
Short people have more risk for heart disease, and now researchers may know why: Genes that govern height also seem…
Read MoreGSK readies ‘bubble boy’ drug as big pharma bets on gene therapy
GlaxoSmithKline is close to seeking European approval for a gene therapy drug to fight adenosine deaminase severe combined immune deficiency…
Read More
Revived search for a TB vaccine may be about to pay off
After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a…
Read More
Implanted magnetic bracelet may help treat chronic heartburn
A tiny magnetic bracelet implanted at the base of the throat is greatly improving life for some people with chronic…
Read More
New robotic surgical institute opens in the Dominican Republic
This week the Metropolitan Hospital of Santiago (HOMS), in the Dominican Republic, opened the first robotic surgery institute in the…
Read More
Pennsylvania baby whose disease prompted improved newborn screenings dies
The little Pennsylvania girl who inspired improved newborn screenings for a rare regenerative disorder has passed away, MyFoxPhilly.com reported. Hannah…
Read More
New hope for Duchenne muscular dystrophy drug
Sarepta Therapeutics Inc’s shares soared 64 percent after it said that the U.S. Food and Drug Administration indicated an alternate…
Read More